Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-004129
Filing Date
2022-01-13
Accepted
2022-01-13 19:53:53
Documents
1
Period of Report
2022-01-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm222967-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm222967-1_4seq1.xml 4 4180
  Complete submission text file 0001104659-22-004129.txt   5617
Mailing Address C/O AMICUS THERAPEUTICS, INC. 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Crowley John F (Reporting) CIK: 0001400973 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 22530192

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations